Mizuho analyst Ann Hynes has maintained an Outperform rating for Medpace Holdings while raising the price target to $586, up from the previous target of $495. The revised target indicates a positive outlook on the stock's future performance despite broader market evaluations.

Rating and Target Changes

The decision to retain the Outperform rating suggests confidence in Medpace Holdings' ability to deliver results relative to its sector peers. The increased price target reflects an updated valuation of the company's worth and growth trajectory.

The adjustment comes as analysts assess Medpace Holdings' position within the industry. The new price target of $586 provides a specific benchmark for investors regarding the firm's expectations for the stock.

Medpace Holdings, Inc. will release its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. A supplemental slide presentation will be available on the "Investors" section of Medpace's website prior to the start of the call.

Conference Call Details

Interested parties must register in advance to participate in the conference call. Registration is required to receive the dial-in number and a unique PIN. Participants are recommended to join 10 minutes prior to the event start time.

Access and Replay

The conference call will be accessible via webcast at investor.medpace.com. A replay of the webcast will be available at the same site approximately one hour after the call concludes. Telephone participants will receive a confirmation email with detailed instructions upon registration.

Company Overview

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO). It provides Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,300 people across 46 countries as of March 31, 2026.